Literature DB >> 19882326

Surgical treatment of cecal cancer in a patient with Glanzmann's thrombasthenia: report of a case.

Akira Kabashima1, Naoyuki Ueda, Yusuke Yonemura, Kojiro Mashino, Kyuzo Fujii, Tetsuo Ikeda, Hideya Tashiro, Hisanobu Sakata.   

Abstract

Glanzmann's thrombasthenia (GT) is a rare inherited platelet disorder with no specific treatment. Prophylactic and therapeutic platelet transfusions work only as supportive treatments. To date, there has been no report of surgical treatment for malignant disease in GT patients. We herein report the case of a 43-year-old woman presenting with cecal cancer with accompanying GT. The patient underwent a laparotomic procedure under general anesthesia for resection of the tumor. A good perioperative course was achieved by the transfusion of ABO-identical and antihistocompatibility locus antigen-matched platelets, without causing any accidental bleeding.

Entities:  

Mesh：

Year:  2009        PMID： 19882326     DOI： 10.1007/s00595-009-3962-4

Source DB:  PubMed          Journal:  Surg Today        ISSN： 0941-1291            Impact factor:   2.549


  14 in total

1.  Peripartum management of a patient with Glanzmann's thrombasthenia using Thrombelastograph.

Authors:  S Monte; G Lyons
Journal:  Br J Anaesth       Date:  2002-05       Impact factor: 9.166

2.  Surgical treatment of a superior sulcus tumor in a patient with idiopathic thrombocytopenic purpura: report of a case.

Authors:  Takahiro Nakajima; Akira Iyoda; Toshihiko Iizasa; Yukio Saitoh; Kenzo Hiroshima; Takehiko Fujisawa
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

3.  Recombinant factor VIIa enhances deposition of platelets with congenital or acquired alpha IIb beta 3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor-independent thrombin generation.

Authors:  Ton Lisman; Sultana Moschatsis; Jelle Adelmeijer; H Karel Nieuwenhuis; Philip G De Groot
Journal:  Blood       Date:  2002-10-31       Impact factor: 22.113

Review 4.  Glanzmann's thrombasthenia in pregnancy: a case and review of the literature.

Authors:  D M Sherer; R Lerner
Journal:  Am J Perinatol       Date:  1999       Impact factor: 1.862

5.  Emergency aortic arch replacement in a patient with idiopathic thrombocytopenic purpura.

Authors:  A Usui; M Kawamura; M Hibi; K Yoshida; F Murakami; J Iwase
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

6.  Glanzmann's thrombasthenia revisited.

Authors:  S A Vuckovic
Journal:  J Emerg Med       Date:  1996 May-Jun       Impact factor: 1.484

Review 7.  Molecular basis of Glanzmann's Thrombasthenia and current strategies in treatment.

Authors:  S Bellucci; J Caen
Journal:  Blood Rev       Date:  2002-09       Impact factor: 8.250

8.  Adult cecoanal intussusception caused by cecum cancer: report of a case.

Authors:  Masahiro Shinoda; Satoshi Hatano; Hirofumi Kawakubo; Toshihiro Kakefuda; Tai Omori; Seiichiro Ishii
Journal:  Surg Today       Date:  2007-08-27       Impact factor: 2.549

9.  A patient with Glanzmann's thrombasthenia for emergent abdominal surgery.

Authors:  Halil Ibrahim Uzunlar; Ahmet Eroglu; Ahmet Can Senel; Habib Bostan; Nesrin Erciyes
Journal:  Anesth Analg       Date:  2004-10       Impact factor: 5.108

Review 10.  To general haemostasis--the evidence-based route.

Authors:  Elisabeth Erhardtsen
Journal:  Pathophysiol Haemost Thromb       Date:  2002
View more
  1 in total

1.  Bleeding risk of surgery and its prevention in patients with inherited platelet disorders.

Authors:  Sara Orsini; Patrizia Noris; Loredana Bury; Paula G Heller; Cristina Santoro; Rezan A Kadir; Nora C Butta; Emanuela Falcinelli; Ana Rosa Cid; Fabrizio Fabris; Marc Fouassier; Koji Miyazaki; Maria Luisa Lozano; Pamela Zúñiga; Claire Flaujac; Gian Marco Podda; Nuria Bermejo; Remi Favier; Yvonne Henskens; Emmanuel De Maistre; Erica De Candia; Andrew D Mumford; Gul Nihal Ozdemir; Ibrahim Eker; Paquita Nurden; Sophie Bayart; Michele P Lambert; James Bussel; Barbara Zieger; Alberto Tosetto; Federica Melazzini; Ana C Glembotsky; Alessandro Pecci; Marco Cattaneo; Nicole Schlegel; Paolo Gresele
Journal:  Haematologica       Date:  2017-04-06       Impact factor: 9.941
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.